Condition
HELLP
Total Trials
4
Recruiting
0
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 65/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 3 (1)
Trial Status
Not Yet Recruiting1
Active Not Recruiting1
Completed1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06074601Active Not Recruiting
MIRACLE of LIFE Study
NCT06452498Phase 3Not Yet Recruiting
Preeclampsia Intervention Netherlands
NCT04725812Phase 2Terminated
Complement Regulation to Undo Systemic Harm in Preeclampsia
NCT02765906Not ApplicableCompleted
Comparing Different Methods of Patient Education on Preeclampsia
Showing all 4 trials